[Elsevier] Cagrilintide每semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study

anatomik Post time 1 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-11-08 04:41
Reward10points

Cagrilintide每semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study

Publication History:
Published June 7, 2026

DOI: 10.1016/S0140-6736(26)01022-6
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Senior Member
  • post

  • reply

  • points

    1842


Return to the list